Standing at a crosswalk, the signal changes from “don’t walk,” to “walk.” You might step out into the street straight away, or you might look both ways before you cross.
Antibody-Drug Conjugate Targeting ROR1 Shows Activity in DLBCL
Among patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), early phase II trial data that was presented at the American Society of Clinical